NEW YORK, March 19 - Start-up pharmacogenomics company Gentris on Tuesday said it has secured $1.5 million in private-equity financing.
Research Triangle Ventures and Exelixis led the round, which also included angel investors.
Gentris said it plans to use the cash to "up-fit" its lab and hire "key senior staff."
The company, founded last year, aims to build a "turnkey pharmacogenomic solution of products and services." It is based in Research Triangle Park, NC.